The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Step Therapy and Biosimilar Substitution Top the Priority List for the Rheumatology Association of Iowa

Step Therapy and Biosimilar Substitution Top the Priority List for the Rheumatology Association of Iowa

May 3, 2017 • By Kelly Tyrrell

  • Tweet
  • Email
Print-Friendly Version / Save PDF

A little more than three years ago, rheumatologist Michael Brooks, MD, FACP, FACR, Cedar Rapids, Iowa, turned years of discussion into something tangible: He and his colleagues got the paperwork and financial requirements in order and officially started the Rheumatology Association of Iowa.

You Might Also Like
  • The ACR’s Advocacy at State Legislature Level in 2016 Focuses on Biosimilars, Step Therapy
  • The ACR and Partners Help Get Legislation Passed in New York to Limit Step Therapy
  • State Step Therapy Laws: Not All Are Created Equal
Also By This Author
  • Timothy Laing, MD, Reappointed to AMA’s Relative Value System Update Committee

“We had been trying to get something going statewide in terms of an advocacy group for many years, but for one reason or another it did not take shape,” Dr. Brooks says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Today, 70–75% of the state’s clinical rheumatologists are members of the association, which has a board and has successfully organized three meetings geared toward practicing rheumatologists.

A Need-Driven Success
“One of the successes of our organization so far is that we’ve been able to get membership from nearly all clinical rheumatology practices in a wide spectrum from across the state,” says Dr. Brooks, president of the association. “I think it’s been successful because there’s a great need for it.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

For example, the cited rates of rheumatoid arthritis are significantly lower in Iowa than in surrounding states, Dr. Brooks says. “It gives us the indication that [many] patients are being missed who have rheumatoid arthritis, and they don’t get diagnosed because they’re not seeing specialists.”

To counter this, the association plans to reach out to primary care physicians to educate them on RA symptoms and let them know there are rheumatologists available to help.

Staying True to Its Intent
Additionally, the association has hewed to its original intent: advocacy.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

At the association’s 2017 annual meeting, representatives from Wellmark Blue Cross/Blue Shield Iowa delivered the keynote address, opening discussions about medical care and improving communication between rheumatologists and the health insurer, which Dr. Brooks says covers 60–80% of the non-Medicare market. He now sits on the insurer’s pharmacy committee, where he advocates for Hawkeye State rheumatologists and their patients.

“We are able to talk to them [Wellmark] about why we need certain medications and about expediting the approval process for our patients, and we help make decisions about their formulary and tiering for everybody on their insurance,” Dr. Brooks says.

Additionally, Dr. Brooks and several colleagues will soon participate in Doctor’s Day in Des Moines, where he, colleagues and patients will meet with state legislators to lobby on behalf of rheumatologic care. This is particularly pertinent, Dr. Brooks says, because the Iowa legislature is considering step therapy and biosimilar bills.

“I was able to discuss legislation with my senator and representative who both supported our step therapy legislation,” Dr. Brooks says. “It passed both houses unanimously and is awaiting the governor’s signature.”

Pages: 1 2 | Single Page

Filed Under: Legislation & Advocacy, Professional Topics Tagged With: advocacy group, Rheumatology Association of Iowa

You Might Also Like:
  • The ACR’s Advocacy at State Legislature Level in 2016 Focuses on Biosimilars, Step Therapy
  • The ACR and Partners Help Get Legislation Passed in New York to Limit Step Therapy
  • State Step Therapy Laws: Not All Are Created Equal
  • Ohio Rheumatologists Advocate for Step Therapy Reform & More

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)